Fluorometric Determination of Cyanate in Plasma by Conversion to 2,4(1 H,3 H)-Quinazolinedione and Separation by High-Performance Liquid Chromatography
A fluorometric high-performance liquid-chromatographic method is described for the determination of cyanate in human plasma. The method is based on the determination of cyanate with 2-aminobenzoic acid (anthranilic acid), leading to a stable cyclic fluorescent product, 2,4(1 H,3 H)-quinazolinedione....
Saved in:
Published in | Analytical biochemistry Vol. 211; no. 1; pp. 23 - 27 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
San Diego, CA
Elsevier Inc
15.05.1993
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A fluorometric high-performance liquid-chromatographic method is described for the determination of cyanate in human plasma. The method is based on the determination of cyanate with 2-aminobenzoic acid (anthranilic acid), leading to a stable cyclic fluorescent product, 2,4(1
H,3
H)-quinazolinedione. The fluorescent product was extracted with ethyl acetate, passed through a cation-exchange resin to eliminate the excess of determination reagent, and then concentrated on a Sep-Pak C-18 cartridge before reversed-phase chromatography and fluorometric detection. The precision of the method was satisfactory (coefficient of variation 2.3%) and the analytical recovery was quantitative (103%). Detection limit was found to be 8 nmol/liter from a 1-ml plasma sample. Cyanate in plasma was stable for 3 months when stored in liquid nitrogen. The mean and SD cyanate level in human plasma from 17 healthy nonsmoking subjects was 45 ± 21 nmol/liter. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0003-2697 1096-0309 |
DOI: | 10.1006/abio.1993.1226 |